Literature DB >> 22915001

Polypharmacy in the elderly from the clinical toxicologist perspective.

H J Heppner1, M Christ, M Gosch, W Mühlberg, P Bahrmann, T Bertsch, C Sieber, K Singler.   

Abstract

INTRODUCTION: Polypharmacy is closely associated with multimorbidity in the elderly and can lead to problems and drug interactions. AIM: This study assessed polypharmacy in the elderly, tracking inquiries to the Poison Information Centre Nuremberg (PICN) and patients needing toxicological intensive care therapy.
METHODS: From 2006-2009, all PICN inquiries involving individuals > 70 years were tracked, as were cases at the Toxicological Intensive Care Unit (T-ICU) regarding adverse drug reactions (ADRs) and drug poisoning.
RESULTS: Of 11,683 PICN calls about pharmaceuticals, 175 (1.5%) were from people > 70 years; 156 (4.8%) of 3,272 T-ICU patients were > 70 years. Calls about psychopharmaceuticals (46.9%) and analgesics (25.7%) were most frequent. Among the T-ICU patients, psychopharmaceuticals like sedatives and hypnotics were frequently involved (20.5%), as were tricyclic antidepressants (17.9%) and analgesics (29.5%). Ethanol was co-ingested by 18.3%.
CONCLUSION: Population-specific poison prevention strategies are needed to reduce toxic exposures. Such strategies could include pharmacist intervention, improved prescriber communication and education regarding the geriatric population, and computerized drug databases.

Entities:  

Mesh:

Year:  2012        PMID: 22915001     DOI: 10.1007/s00391-012-0383-6

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  49 in total

1.  Readmissions and adverse drug reactions in internal medicine: the economic impact.

Authors:  H Dormann; A Neubert; M Criegee-Rieck; T Egger; M Radespiel-Tröger; T Azaz-Livshits; M Levy; K Brune; E G Hahn
Journal:  J Intern Med       Date:  2004-06       Impact factor: 8.989

2.  [Multiple drug therapy - a challenge for an aging society].

Authors:  Markus Gosch; Regina E Roller
Journal:  Wien Med Wochenschr       Date:  2010-06

Review 3.  Medication and falls: risk and optimization.

Authors:  Nichola Boyle; Vasi Naganathan; Robert G Cumming
Journal:  Clin Geriatr Med       Date:  2010-08-04       Impact factor: 3.076

4.  [Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center)].

Authors:  C Ciorciaro; K Hartmann; M Kuhn
Journal:  Schweiz Med Wochenschr       Date:  1998-02-14

5.  Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands.

Authors:  Rikje Ruiter; Loes E Visser; Eline M Rodenburg; Gianluca Trifiró; Gijsbertus Ziere; Bruno H Stricker
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

6.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

7.  Minimal dose for severe poisoning and influencing factors in acute human clozapine intoxication: a 13-year retrospective study.

Authors:  Isabel Krämer; Christine Rauber-Lüthy; Hugo Kupferschmidt; Stephan Krähenbühl; Alessandro Ceschi
Journal:  Clin Neuropharmacol       Date:  2010 Sep-Oct       Impact factor: 1.592

Review 8.  Medication-related falls in the elderly: causative factors and preventive strategies.

Authors:  Allen R Huang; Louise Mallet; Christian M Rochefort; Tewodros Eguale; David L Buckeridge; Robyn Tamblyn
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

Review 9.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons.

Authors:  John C Woolcott; Kathryn J Richardson; Matthew O Wiens; Bhavini Patel; Judith Marin; Karim M Khan; Carlo A Marra
Journal:  Arch Intern Med       Date:  2009-11-23

10.  Adverse drug reactions as the cause of emergency department admission: focus on the elderly.

Authors:  Maria Teresa Ventura; Rocco Laddaga; Pierfranco Cavallera; Piervito Pugliese; Roberto A Tummolo; Rosalba Buquicchio; Paola Pierucci; Gianni Passalacqua
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-09       Impact factor: 2.730

View more
  6 in total

1.  Factors influencing quality of bowel preparation for colonoscopy.

Authors:  Ronald V Romero; Sanjiv Mahadeva
Journal:  World J Gastrointest Endosc       Date:  2013-02-16

Review 2.  The next therapeutic challenge in HIV: polypharmacy.

Authors:  E Jennifer Edelman; Kirsha S Gordon; Janis Glover; Ian R McNicholl; David A Fiellin; Amy C Justice
Journal:  Drugs Aging       Date:  2013-08       Impact factor: 3.923

Review 3.  Predictors of Inadequate Bowel Preparation and Salvage Options on Colonoscopy.

Authors:  Ju Sung Sim; Ja Seol Koo
Journal:  Clin Endosc       Date:  2016-07-29

4.  Number of medications and adverse drug events by unintentional poisoning among older adults in consideration of inappropriate drug use: a Swedish population-based matched case-control study.

Authors:  Christian Rausch; L Laflamme; U Bültmann; J Möller
Journal:  Eur J Clin Pharmacol       Date:  2017-03-09       Impact factor: 2.953

5.  Predictors and colonoscopy outcomes of inadequate bowel cleansing: a 10-year experience in 28,725 patients.

Authors:  Fadi Abu Baker; Amir Mari; Smadar Nafrin; Muhammed Suki; Baruch Ovadia; Oren Gal; Yael Kopelamn
Journal:  Ann Gastroenterol       Date:  2019-07-06

6.  Optimizing polypharmacy among elderly hospital patients with chronic diseases--study protocol of the cluster randomized controlled POLITE-RCT trial.

Authors:  Christin Löffler; Eva Drewelow; Susanne D Paschka; Martina Frankenstein; Julia Eger; Lisa Jatsch; Emil C Reisinger; Johannes F Hallauer; Bernd Drewelow; Karen Heidorn; Helmut Schröder; Anja Wollny; Günther Kundt; Christian Schmidt; Attila Altiner
Journal:  Implement Sci       Date:  2014-10-06       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.